Business Description
VBI Vaccines Inc
NAICS : 325412
SIC : 3741
ISIN : CA7838992062
Description
VBI Vaccines Inc is a commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.45 | |||||
| Equity-to-Asset | 0.09 | |||||
| Debt-to-Equity | 7.05 | |||||
| Debt-to-EBITDA | -0.64 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -12.91 | |||||
| Beneish M-Score | 13.61 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 56.3 | |||||
| 3-Year EBITDA Growth Rate | 2.1 | |||||
| 3-Year EPS without NRI Growth Rate | 13.9 | |||||
| 3-Year FCF Growth Rate | 15.6 | |||||
| 3-Year Book Growth Rate | -75.3 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.48 | |||||
| Quick Ratio | 0.37 | |||||
| Cash Ratio | 0.31 | |||||
| Days Inventory | 211.63 | |||||
| Days Sales Outstanding | 7.9 | |||||
| Days Payable | 254.43 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -42.7 | |||||
| Shareholder Yield % | -57.93 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -44.09 | |||||
| Operating Margin % | -637.11 | |||||
| Net Margin % | -1069.29 | |||||
| FCF Margin % | -4436.47 | |||||
| ROE % | -319.38 | |||||
| ROA % | -82.95 | |||||
| ROIC % | -59.11 | |||||
| ROC (Joel Greenblatt) % | -634.62 | |||||
| ROCE % | -135.64 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.24 | |||||
| PB Ratio | 1.92 | |||||
| EV-to-EBIT | -0.55 | |||||
| EV-to-EBITDA | -0.56 | |||||
| EV-to-Revenue | 5.36 | |||||
| EV-to-FCF | -0.75 | |||||
| Earnings Yield (Greenblatt) % | -181.82 | |||||
| FCF Yield % | -359.28 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:SVACD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
VBI Vaccines Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.815 | ||
| EPS (TTM) ($) | 0 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 3.4 - 17.45 | ||
| Shares Outstanding (Mil) | 18.91 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
VBI Vaccines Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
VBI Vaccines Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
VBI Vaccines Inc Frequently Asked Questions
What is VBI Vaccines Inc(SVACD)'s stock price today?
The current price of SVACD is $4.61. The 52 week high of SVACD is $17.45 and 52 week low is $3.40.
When is next earnings date of VBI Vaccines Inc(SVACD)?
The next earnings date of VBI Vaccines Inc(SVACD) is 2024-05-15 Est..
Does VBI Vaccines Inc(SVACD) pay dividends? If so, how much?
VBI Vaccines Inc(SVACD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers